17 May 2024 in Journal of Comparative Pathology
CFCarlos E. Fonseca-Alves
30 July 2024 in Brazilian Journal of Veterinary Pathology
Reports on thyroid carcinomas in bovines are scarce. An 18-year-old Nellore cow was referred to a veterinary hospital due to lateral recumbency lasting one day after falling on irregular terrain. The patient was clinically diagnosed with spinal cord injury. Necropsy and histopathology revealed a thyroid tubule papillary carcinoma. Immunohistochemical analysis revealed discrete positive cells for calcitonin, moderately positive cells for thyroid transcription factor 1 (TTF-1), and strongly positive cells for thyroglobulin in the thyroid gland. Thus, this report describes a case of a mixed tubule papillary carcinoma derived from both medullary and follicular cells in a Nellore cow.
7 May 2026 in Brazilian Journal of Veterinary Pathology
Diffuse immunoexpression of Preferentially Expressed Antigen in Melanoma (PRAME) is an ancillary diagnostic tool for distinguishing human melanoma from melanocytic nevi. Canine melanocytic neoplasms are common in veterinary diagnostic practice; however, no established immunohistochemical biomarkers of malignancy are currently available. This case series study aimed to investigate the immunoexpression of the anti-PRAME (EPR20330) antibody in canine melanocytic tumors. Two cutaneous melanocytomas and six melanomas from distinct anatomical sites (haired skin, oral cavity and feet) were submitted to immunohistochemistry protocol with anti-PRAME antibody (clone EPR20330, dilution 1:100, Abcam) overnight at 4°C. Nuclear immunolabeling was scored on a 5-point scale based on the percentage of positive tumor cells (0: none; 1: 1–25%; 2: 26–50%; 3: 51–75%; 4/diffuse: ≥76%). The two evaluated melanocytomas were PRAME-negative. All melanomas were PRAME-positive and diffuse nuclear immunolabeling was observed in 4/6 cases. To the best of our knowledge, this is the first study to demonstrate the immunohistochemical expression of the anti-PRAME antibody (clone EPR20330) in canine melanomas. Our preliminary findings, based on a limited sample size, suggest that PRAME may represent a promising ancillary diagnostic marker for these tumors, similar to its use in human samples. However, further studies with larger cohorts are needed to better characterize its labeling patterns in canine melanocytic neoplasms and to confirm its diagnostic value in veterinary pathology.
20 October 2025 in Veterinary Research Communications
1 January 2023 in Brazilian Journal of Veterinary Pathology
The most significant interest in veterinary oncology is occupied by tumors of a mixed nature, which are represented by the direct interaction of epithelial and mesenchymal components. According to some data, the formation of cell lineage of mesenchymal cells occurs due to the transformation of epidermal basket cells surrounding the glandular epithelium.